Title : Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.

Pub. Date : 2020 Jul

PMID : 32279331






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In ETV6-ABL1 positive patients, a durable CHR was achieved by 4/9 patients (imatinib 1/5, nilotinib 2/3, dasatinib 1/1). Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens